Evidence map›Paper›PMID 27756400›Full record

ArticleBMC research notes2016

Recurrent amebic liver abscesses over a 16-year period: a case report.

D Creemers-Schild, P J J van Genderen, L G Visser, J J van Hellemond, P J Wismans

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in BMC research notes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Tropical medicine and health · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

D Creemers-SchildInstitute for Tropical Diseases, Harbour Hospital, Rotterdam, The Netherlands.
P J J van GenderenInstitute for Tropical Diseases, Harbour Hospital, Rotterdam, The Netherlands.
L G VisserDepartment of Infectious Diseases, Leiden University Medical Center, Leiden, The Netherlands.
J J van HellemondDepartment of Medical Microbiology and Infectious Diseases, Erasmus University Medical Center and Institute for Tropical Diseases, Rotterdam Harbour Hospital, MC, Room Na-901K (Secr. Office), P.O. Box 2040, 3000 CA, Rotterdam, The Netherlands. j.vanhellemond@erasmusmc.nl.
P J WismansInstitute for Tropical Diseases, Harbour Hospital, Rotterdam, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAmebic liver abscess is a rare disease in high-income countries. Recurrence of amebic liver abscess is even rarer with only a few previous reports. Here we present a patient who developed three subsequent amebic liver abscesses over a sixteen-year period. CASE PRESENTATION: A Caucasian male developed recurrent amebic liver abscesses, when aged 23, 27 and 39 years. Only on the first occasion did this coincide with a recent visit to the tropics. The patient received adequate treatment during each episode. Possible explanations are persistent asymptomatic carrier state, cysts passage in his family, re-infection or chance.

conclusionWe describe the unusual case of a healthy male who developed recurrent amebic liver abscesses over a long period despite adequate treatment. Possible pathophysiological explanations are explored.

Indexed as

AdultFuransHumansLiver Abscess, AmebicMaleMetronidazoleMiddle AgedRecurrenceYoung Adultdiloxanide furoateFuransMetronidazoleAmebiasisCarrier state environmentEntamoeba histolyticaImmune responseRelapseTreatment

Identifiers

PMID27756400
PMCPMC5069943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.